Sunshine Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 340.3%.

Top 24 shareholders own 15.96% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.31%	L1 Capital Pty. Limited	52,857	US$64.0k	0%	no data
3.75%	Altium Capital Management LP	37,280	US$45.1k	0%	0.04%
3.72%	Malek Chamoun	37,000	US$44.8k	0%	no data
2.14%	Armistice Capital LLC	21,300	US$25.8k	119%	no data
0.29%	Bridgeway Capital Management, LLC	2,861	US$3.5k	0%	no data
0.19%	Citadel Advisors LLC	1,852	US$2.2k	0%	no data
0.18%	Camille Sebaaly	1,745	US$2.1k	0%	no data
0.12%	Abderrazzak Merzouki	1,167	US$1.4k	0%	no data
0.12%	Steve Slilaty	1,167	US$1.4k	0%	no data
0.067%	Renaissance Technologies LLC	666	US$805.9	0%	no data
0.024%	Virtu Financial LLC, Asset Management Arm	238	US$288.0	0%	no data
0.02%	Geode Capital Management, LLC	201	US$243.2	0%	no data
0.018%	XTX Holdings Limited, Asset Management Arm	174	US$210.6	0%	no data
0.01%	Merrill Lynch & Co. Inc., Banking Investments	100	US$121.1	0%	no data
0.006%	National Bank Investments Inc.	60	US$72.6	0%	no data
0.0043%	Trt Pharma Inc.	43	US$52.0	0%	no data
0.0022%	UBS Asset Management AG	22	US$26.6	2,100%	no data
0.0016%	Rabi Kiderchah	16	US$19.4	0%	no data
0.0007%	Osaic Wealth, Inc. , Asset Management Arm	7	US$8.4	-78.1%	no data
0.0002%	Main Street Group, Ltd	2	US$2.4	0%	no data
0.0001%	Rise Advisors, Llc , Asset Management Arm	1	US$1.2	0%	no data
0.0001%	Securities America Advisors, Inc.	1	US$1.2	0%	no data
0.0001%	Morgan Stanley, Investment Banking and Brokerage Investments	1	US$1.2	0%	no data
0.0001%	Oliver Lagore Vanvalin Investment Group, Inc.	1	US$1.2	0%	no data